Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 9;18(3):e0282271.
doi: 10.1371/journal.pone.0282271. eCollection 2023.

Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders

Affiliations

Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders

Monika A Waszczuk et al. PLoS One. .

Abstract

Background: Genetic factors contribute to individual differences in the severity of coronavirus disease 2019 (COVID-19). A portion of genetic predisposition can be captured using polygenic risk scores (PRS). Relatively little is known about the associations between PRS and COVID-19 severity or post-acute COVID-19 in community-dwelling individuals.

Methods: Participants in this study were 983 World Trade Center responders infected for the first time with SARS-CoV-2 (mean age at infection = 56.06; 93.4% male; 82.7% European ancestry). Seventy-five (7.6%) responders were in the severe COVID-19 category; 306 (31.1%) reported at least one post-acute COVID-19 symptom at 4-week follow-up. Analyses were adjusted for population stratification and demographic covariates.

Findings: The asthma PRS was associated with severe COVID-19 category (odds ratio [OR] = 1.61, 95% confidence interval: 1.17-2.21) and more severe COVID-19 symptomatology (β = .09, p = .01), independently of respiratory disease diagnosis. Severe COVID-19 category was also associated with the allergic disease PRS (OR = 1.97, [1.26-3.07]) and the PRS for COVID-19 hospitalization (OR = 1.35, [1.01-1.82]). PRS for coronary artery disease and type II diabetes were not associated with COVID-19 severity.

Conclusion: Recently developed polygenic biomarkers for asthma, allergic disease, and COVID-19 hospitalization capture some of the individual differences in severity and clinical course of COVID-19 illness in a community population.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases. 2020;20(5):533–4. doi: 10.1016/S1473-3099(20)30120-1 - DOI - PMC - PubMed
    1. Lhuillier E, Yang Y, Morozova O, Clouston SA, Yang X, Waszczuk MA, et al.. The Impact of World Trade Center Related Medical Conditions on the Severity of COVID-19 Disease and Its Long-Term Sequelae. International Journal of Environmental Research and Public Health. 2022;19(12):6963. doi: 10.3390/ijerph19126963 - DOI - PMC - PubMed
    1. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al.. Post-acute COVID-19 syndrome. Nature medicine. 2021;27(4):601–15. doi: 10.1038/s41591-021-01283-z - DOI - PMC - PubMed
    1. Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al.. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA network open. 2021;4(10):e2128568–e. doi: 10.1001/jamanetworkopen.2021.28568 - DOI - PMC - PubMed
    1. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6. doi: 10.1038/s41586-020-2521-4 - DOI - PMC - PubMed

Publication types